202 Study 1 was a Phase 2 study in patients with active but clinically stable plaque psoriasis involving  10% of the body surface area that were  18 years old.
Uuring 1 oli 2. faasi uuring ≥18- aastastel patsientidel aktiivse, kuid kliiniliselt stabiilse psoriaasiga, mis haaras ≥10% keha pinnast.